Back to search

Article

ADH4 is a TP53-associated immunometabolic signature for prediction of prognosis in hepatocellular carcinoma

2022-02-14

Abstract excerpt

<h4>Background: </h4> Tumor protein p53 (TP53) is one of the most frequent mutated genes in hepatocellular carcinoma (HCC), whose mutations influenced tumor microenvironment (TME) and associated with a worse prognosis. Thus, finding out an accurate prognostic signature could be beneficial for improving the prognosis of HCC. <h4>Methods:</h4> HCC genetic mutation data, transcriptome data and clinical data were down...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61e82810-a75d-555a-b457-145dc4685196
DOI
10.21203/rs.3.rs-1342483/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ADH4 is a TP53-associated immunometabolic signature for prediction of prognosis in hepatocellular carcinomaDOI 10.21203/rs.3.rs-1342483/v1
ADH4 Is A TP53-Associated Immune-Metabolic Signature For The Prediction Of Prognosis In Hepatocellular CarcinomaSemantic proximity
Alcohol dehydrogenase 4 is a TP53‑associated gene signature for the prediction of prognosis in hepatocellular carcinomaSemantic proximity
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinomaSemantic proximity
Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinomaSemantic proximity
Development of Prognostic Model Based on Five-gene Related to Tumor Mutation Burden in Hepatocellular CarcinomaSemantic proximity
A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genesSemantic proximity
Identification of a Novel PPAR Signature for Predicting Prognosis and Immune Microenvironment in Hepatocellular CarcinomaSemantic proximity
A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacySemantic proximity
From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapySemantic proximity
Construction and validation of novel lactate metabolism molecular subtypes in hepatocellular carcinoma based on multi-omics analysisSemantic proximity
Identification of Novel Characteristics in TP53-Mutant Hepatocellular Carcinoma Using BioinformaticsSemantic proximity
ADH4—a potential prognostic marker for hepatocellular carcinoma with possible immune-related implicationsSemantic proximity
Select a neighboring publication to make it the new centre.